Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Research news

Mortality rates for buprenorphine versus methadone treatments

July 17, 2022

Leo Sher, M.D.

The research report “A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder” has been published in Acta Psychiatrica Scandinavica online ahead of print (1). Researchers compared all-cause mortality, overdose mortality, and suicide mortality rates for buprenorphine and methadone treatments among a large sample of U.S. Department of Veterans Affairs patients with opioid use disorder.

The cohort consisted of 61,997 patients with opioid use disorder who received opioid agonist treatment from 2010 to 2019. 92.7% of patients were male. The mean age of individuals included in the study was 47.9 (SD=14.1) years. Patients were followed for a median of 2 (IQR=1,4) calendar years. The total follow up time was 189,950 calendar years. Compared to patients who received methadone, those who received buprenorphine were more likely to be young, white, rural, housed, and physically healthy.

The authors found significant reductions in all-cause and suicide mortality for buprenorphine relative to methadone. The authors reported that this held true across several good analytic designs that can account for selection bias and unmeasured confounding. No difference was identified for overdose mortality.

The authors conclude that buprenorphine has substantial and statistically significant benefits over methadone for the outcomes of all-cause mortality and suicide mortality. The authors suggest that the results of the study support the less restrictive prescribing practices for buprenorphine as opioid agonist treatment in the U.S.

Reference

  1. Gottlieb DJ, Shiner B, Hoyt JE, Riblet NB, Peltzman T, Teja N, Watts BV. A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder. Acta Psychiatr Scand. 2022 Jul 15. doi: 10.1111/acps.13477. Epub ahead of print.

Related Posts

Research news /

Suicidality in individuals with schizotypal personality disorder

Research news /

Six minutes of daily high-intensity exercise can slow brain aging and delay the onset of neurodegenerative diseases

Research news /

Mortality in patients with schizophrenia: a review and meta-analysis

‹ Leading world experts on suicide. Expertscape, the June 20, 2022, report › Long COVID and suicide

Editorials

  • Warren v. Dinter and the end of curbside medicine
  • Suicide medical malpractice
  • Dr. Slavko Ziherl, an eminent Slovenian psychiatrist
  • Prevention of suicidal behavior in individuals with diabetes

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Suicidality in individuals with schizotypal personality disorder
  • Six minutes of daily high-intensity exercise can slow brain aging and delay the onset of neurodegenerative diseases
  • Mortality in patients with schizophrenia: a review and meta-analysis
  • Long COVID, psychiatric disorders and suicidality

Latest News

  • Leading world experts on suicide. Expertscape, the January 9, 2023, report
  • Best universities in the world
  • Geriatric Psychiatry Fellowship
  • 2022 National Veteran Suicide Prevention Annual Report

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Plasma testosterone levels in bipolar suicide attempters
  • Teaching medical professionals and trainees about suicide prevention
  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors
  • Treatment of suicide attempters with bipolar disorder: a randomized clinical trial

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2022 AVCalc LLC. All rights reserved worldwide.